For the Inventor, By the Inventor

Enter assignee name

South San Francisco, CA, United States of America

Sutro Biopharma, Inc.

Calculating rank

USPTO Granted Patents = 55

% Expired Patents = 14.5

EPO Patents = 18

Forward Citations = 186

Loading Chart...

Loading Chart...

62 inventors (with patents filed for the assignee):

Christopher D Thanos (25 out of 62 patents)

Ryan Stafford (20 out of 24 patents)

Gang Yin (18 out of 19 patents)

4. Alice Yam (14 out of 15 patents)

5. Avinash Gill (11 out of 11 patents)

6. Kalyani Penta (10 out of 11 patents)

7. Xiaofan Li (10 out of 11 patents)

8. Ramesh Baliga (8 out of 29 patents)

9. Wenjin Yang (8 out of 37 patents)

10. Junhao Yang (7 out of 10 patents)

11. Sunil Bajad (7 out of 7 patents)

12. Krishna Bajjuri (6 out of 6 patents)

13. Leslie McEvoy (6 out of 8 patents)

14. Sonia Pollitt (6 out of 7 patents)

15. Chris Murray (6 out of 6 patents)

Core Competencies:

Antibody Conjugates

Modified Amino Acids

Bacterial Expression

Immunomodulator

Full-Length Antibodies

Non-Natural Amino Acids

Proteolytic Inactivation

Chaperone Expression

Hemiasterlin Derivatives

Ribosomal Display Technology

Anti-CD74 Antibodies

Codon Optimization

55 patents: Sort by Forward Citations

1. 12673983 - E COLI STRAINS FOR PRODUCING FULL-LENGTH ANTIBODIES (2026-07-07),

2. 12540197 - ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES, COMPOSITIONS COMPRISING ANTI-TISSUE FACTOR ANTIBODIES OR ANTIBODY CONJUGATES, AND METHODS OF MAKING AND USING ANTI-TISSUE FACTOR ANTIBODIES AND ANTIBODY CONJUGATES (2026-02-03),

3. 12534465 - 5H-PYRROLO[3,2-d]PYRIMIDINE-2,4-DIAMINO COMPOUNDS AND ANTIBODY CONJUGATES THEREOF (2026-01-27),

4. 12427201 - Anti-folate receptor antibody conjugates, compositions comprising anti-folate receptor antibody conjugates, and methods of making and using anti-folate receptor antibody conjugates (2025-09-30),

5. 12410393 - strains having an oxidative cytoplasm (2025-09-09),

6. 12398197 - Antibodies with engineered CH2 domains, compositions thereof and methods of using the same (2025-08-26),

7. 12351850 - Methods of producing full-length antibodies using (2025-07-08),

8. 12269801 - Modified amino acids (2025-04-08),

9. 12252552 - Modified Fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use (2025-03-18),

10. 12226490 - Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates preliminary class (2025-02-18),

11. 12144869 - Anti-ROR1 antibody conjugates, compositions comprising anti ROR1 antibody conjugates, and methods of making and using anti-ROR1 antibody conjugates (2024-11-19),

12. 12098406 - Formulations for drying bacterial cell extracts (2024-09-24),

13. 12071477 - Anti-folate receptor alpha antibody conjugated with hemiasterlins (2024-08-27),

14. 11993658 - Anti-BCMA antibodies and treatment methods (2024-05-28),

15. 11958909 - Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use (2024-04-16),

Company Overview

Sutro Biopharma, Inc. is a biotechnology company based in South San Francisco, California, specializing in antibody engineering. The company focuses on developing innovative therapeutics through its proprietary platform that enables the creation of antibody-drug conjugates and other advanced biologics. Sutro's core technologies include modified amino acids, bacterial expression systems, and immunomodulators, positioning it at the forefront of next-generation antibody therapies aimed at treating various diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 10 2026

55 Patents

#27 in South San Francisco, CA

#1,520 in California

#6,470 in US

#12,953 in the World

South San Francisco, CA, United States of America

Sutro Biopharma, Inc.

Forward Citations = 186

62 inventors:

Christopher D Thanos (25 out of 62 patents)

Ryan Stafford (20 out of 24 patents)

Gang Yin (18 out of 19 patents)

4. Alice Yam (14 out of 15 patents)

5. Avinash Gill (11 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Sutro Biopharma, Inc.. Retrieved from https://idiyas.com/company/sutro-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…